Recent Updates
Recently added Catalysts
IRON

Disc Medicine to Present at the European Hematology Association (EHA) 2021 Virtual Congress

Monday, May 24, 2021 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Disc Medicine to Present at the European Hematology Association (EHA) 2021 Virtual Congress

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+45%
120-day peak, hindsight
Typical move
3.9%
average across 7 past catalysts
Cash runway
~48 mo
Minimal dilution risk
Lead asset
DISC-0974
Phase 2 · Inflammatory Bowel Disease (IBD)

Full Press Release Details

Disc Medicine to Present at the European Hematology Association (EHA) 2021 Virtual Congress.
ShareAdd on Google
Tags: IRON Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: May 24, 2021

Biotech snapshot

Cash runway
$718M liquidity · $15M/mo burn
~48 mo
Minimal dilution risk
Lead asset
DISC-0974Phase 2
Inflammatory Bowel Disease (IBD) →

Catalyst track record

+45%
best trade around IRON's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for IRON.

See every catalyst's timing & PoA →